Roscovitine induces cell death and morphological changes indicative of apoptosis in MDA-MB-231 breast cancer cells

Cancer Research

Volumn 59, Issue 8, 1999, Pages 1903-1910

  Mgbonyebi, Ozuem P ^a   Russo, Jose ^a   Russo, Irma H ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ROSCOVITINE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CELL DEATH; DRUG EFFECT; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ACTINS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CELL SIZE; CELL SURVIVAL; CHROMATIN; CYCLIN-DEPENDENT KINASES; DNA, NEOPLASM; HUMANS; MICROFILAMENTS; PURINES; RECEPTORS, ESTROGEN; TUMOR CELLS, CULTURED;

EID: 0033561531     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Menck, H. R., Jessup, J. M., Eyre, H. J., Cunningham, M. P., Fremgen, A., Murphy, G. P., and Winchester, D. P. Clinical highlights from National Cancer Data Base: 1997. CA Cancer J. Clin., 47: 161-170, 1997.
2. Beatson, G. T. On the treatment of inoperable cases of mamma. Suggestion for anew method of treatment with illustrative cases. Lancet, 2: 104-107, 1896.
3. Litherland, S., and Jackson, I. M. Antiestrogens in the management of hormone-dependent cancer. Cancer Treat. Rev., 15: 183-184, 1988.
4. Henderson, J. C. Endocrine therapy of metastatic breast cancer. Breast Dis., 2: 559-603, 1991.
5. Dowsett, M., Stein, R. C., and Coombes, R. C. Aromatization inhibition alone or in combination with GnRH agonists for the treatment of premenopausal breast cancer patients. J. Steroid Biochem. Mol. Biol., 41: 155-159, 1992.
6. Demers, L. M. Effects of fadrozole (CGS 16949A) and letrozole (CGS20269) on the inhibition of aromatase activity in breast cancer patients. Breast Cancer Res. Treat., 10: 95-102, 1994.
7. Lerner, L. J., and Jordan, V. C. Development of antiestrogens and their use in breast cancer: Eighth Cain Memorial Award Lecture. Cancer Res., 50: 4177-4189, 1990.
8. Jaiyesimi, I. A., Buzdar, A. U., Decker, D. A., and Hortobagyi, G. N. Use of tamoxifen for breast cancer: twenty-eight years later. J. Clin. Oncol., 13: 513-529, 1995.
9. Buzdar, A. U., and Hortobagyi, G. Update on endocrine therapy for breast cancer. Clin. Cancer Res., 4: 527-534, 1998.
10. Wang, W. L., Porter, W. W., Burghardt, R., and Safe, S. H. Mechanism of inhibition of MDA-MB-468 breast cancer cell growth by 2,3,7,8-tetrachlorodibenzo-p-diioxin. Carcinogenesis (Lond.), 18: 925-933, 1997.
11. 3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines. Cancer Res., 55: 2822-2830, 1995
12. Meijer, L. Chemical inhibitors of cyclin-dependent kinases. Trends Cell Biol., 6: 393-397, 1996.
13. Havlicek, L., Hanus, J., Leclerc, S., Meijer, L., Shaw, G., and Strnad, M. Cytokin-derived cyclin-dependent inhibitors: synthesis and cdc2 inhibitory activity of olomoucine and related compounds. J. Med. Chem., 40: 408-412, 1997.
14. Mgbonyebi, O. P., Russo, J., and Russo, I. H. Roscovitine inhibits the proliferative activity of immortal and neoplastic human breast epithelial cells. Anticancer Res., 18: 751-756, 1998.
15. Meijer, L., Bordne, A., Mulner, O., Chong, J. P. J, Blow, J. J., Inagaki, M., Delcros, J-G., and Moulinoux, J-P. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2, and cdk5. Eur. J. Biochem., 243: 527-536, 1997.
16. Azevedo, W. F., Leclerc, S., Meijer, L., Havlicek, I., Strnad, M., and Kim, S. H. Inhibition of cyclin-dependent kinases by a purine analogs: crystal structure of human cdk2 complexed with roscovitine. Eur. J. Biochem., 241: 518-526, 1997.
17. Rudolph, B., Saffric, J. Z., Henglein, B., Muller, R., Ansorge, W., and Eilers, M. Activation of cyclin-dependent kinases by Myc mediates induction of cyclin A but not apoptosis. EMBO J., 15: 3065-3076, 1996.
18. Wong, N. C., Mueller, B. M., Barbas, C. F., Ruminski, P., Quaranta, V., Lin, E. C. K., and Smith, J. W. Alpha-Integrins mediate adhesion and migration of breast carcinoma cell lines. Clin. Exp. Metastasis. 16: 50-61, 1998.
19. Brunner, N., Zugmaier, G., Bano, M., Ennis, B., Clarke, R., Cullen, K. J., Kern, F. G., Dickson R. B., and Lippman, M. E. Endocrine therapy of human breast cancer cells: the role of polypeptide growth factors. Cancer Cells (Cold Spring Harbor). 1: 81-85, 1989.
20. Callahan, R., and Salomon, D. S. Oncogenes, tumor suppressor genes and growth factors in breast cancer: novel targets for diagnosis, prognosis and therapy. Cancer Surv., 18: 35-56, 1993.
21. Zhou, J-N., and Linder, S. Expression of CDK inhibitor genes in immortalized and carcinoma derived breast cell lines. Anticancer Res., 16: 1931-1935, 1996.
22. Kaur, G., Steltler-Stevenson, M., Sebers, S., Worland, P., Sedlacek, H., Myers, C., Czech, J., Naik, R., and Sansville, E. Growth inhibition with reversible cell cycle arrest of carcinoma cells by flavone L86-8275. J. Natl. Cancer Inst., 84: 1736-1740, 1992.
23. Mgbonyebi, O. P., Russo, J., and Russo, I H. Antiproliferative effect of synthetic resveratrol on human breast epithelial cells. Int. J. Oncol., 12: 865-869, 1998.
24. Cotter, T. C., Lennon, S. V., Glyn, J. M., and Green, D. R. Microfilament-disrupting agents prevent the formation of apoptotic bodies in tumor cells undergoing apoptosis. Cancer Res., 52: 997-1005, 1992.
25. Ishiyama, M., Tominaga, H., Shiga, M., Sasamoto, K., Ohkura, Y., and Ueno, K. A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet. Biol. Pharmacol. Bull., 19: 1518-1520, 1996.
26. Wen, L-P., Fahrni, J. A., Troie, S., Guan, J-L., Orth, K., and Rosen, J. A. Cleavage of focal adhesion kinase by caspases during apoptosis. J. Biol. Chem., 272: 26056-26061, 1997.
27. Foghi, A., Ravandi, A., Teerds, K. J., Van Der Donk, H., Kuksis, A., and Dorrington, J. Fas-induced apoptosis in rat thecal/interstitial cells signals through sphingomyelin-ceramide pathway. Endocrinology, 139: 2041-2047, 1998.
28. Schafer, R., Karbach, D., and Hoppe, J. Multiple intracellular pathways interfere with the activation of a CPP32-like protease induced by serum deprivation of AKR-2B cells. Exp. Cell Res., 240: 28-39, 1998.
29. Iseki, H., Ko, T. C., Xue, X. Y., Seapan, A., Hellmich, M. R., and Townsend, C. M., Jr. Cyclin-dependent kinase inhibitors block proliferation of human gastric cancer cells. Surgery. 122: 187-195, 1998.
30. Pippin, J. W., Qu, Q., Meijer, L., and Shankland, S. J. Direct in vivo inhibition of the nuclear cell cycle cascade in experimental mesangial proliferative glomerulonephritis with roscovitine, a novel cyclin-dependent kinase antagonist. J. Clin. Invest., 100: 2512-2520, 1997.
31. Yakisich, J. S., Siden, A., Vargas, V. I., Eneroth, P., and Cruz, M. Early inhibition of DNA synthesis in developing rat cerebral cortex by purine analogues olomoucine and roscovitine, Biochem. Biophys. Res. Commun., 243: 674-677, 1998.
32. Barry, M. A., Behnke, C. A., and Eastman, A. Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem. Pharmacol., 40: 2353-2362, 1990.
33. Martin, S. J., and Cotter, T. G. Specific loss of microtubules in HL-60 cells leads to programmed cell death (apoptosis). Biochem. Soc. Trans., 18: 299-301, 1990.
34. Bertrand, R., Kerrigan, D., Sarang, M., and Pommier, Y. Cell death by topoisomerase inhibitors. Biochem. Pharmacol., 42: 77-85, 1992.
35. klp1 induces cell cycle arrest and loss of cyclin-Cdk activity in human breast cancer cells. Oncogene, 14: 2283-2289, 1997.
36. Kip1 overexpression causes apoptotic death of mammalian cells. Oncogene, 15: 2991-2997, 1997.
37. Alaoui, S. E., Lawry, J., and Griffin, M. The cell cycle and induction of apoptosis in a hamster fibrosarcoma cell line treated with anticancer drugs: its importance to solid tumor chemotherapy. J. Neuro-oncol., 31: 195-207, 1997.
38. Goh, E. L., Pircher, T. J., Wood, T. J., Norstedt, G., Graichen, R., and Lobie, P. E. Growth hormone-induced reorganization of actin cytoskeleton is not required for STATS (signal transducer and activator of transcription 5)-mediated transcription. Endocrinology, 138: 3207-3215, 1997.
39. Martin, S. S., Rose, D. W., Saltiel, A. R., Klippel, A., Williams, L. T., and Olefsky, J. M. Phosphatidylinositol 3-kinase is necessary and sufficient for insulin-stimulated stress fiber breakdown. Endocrinology, 137: 5045-5054, 1996.
40. Ridley, A. J., and Hall, A. The small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factors. Cell, 70: 389-399, 1992.
41. Nobes, C. D., and Hall, A. Rho, Rac, and Cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell, 81: 53-62, 1995.
42. Hall, A. Rho GTPases and the actin cytoskeleton. Science (Washington DC), 279: 509-514, 1998.
43. Wylie, A. H., Kerr, J. F. R., and Currie, A. R. Cell death: the significance of apoptosis. Int. Rev. Cytol., 68: 251-306, 1980.
44. Kornberg, L., Earp, H. S., Parsons, J. T., Shaller, M., and Juliano, R. L. Cell adhesion or integrin clustering increases phosphorylation of focal adhesion-associated tyrosine kinase. J. Biol. Chem., 267: 23439-23442, 1992.
45. Haimovich, B., Lipfert, L., Brugge, J. S., and Shattil, S. J. Tyrosine phosphorylation and cytoskeletal reorganization in platelets are triggered by interaction of integrin receptors with their immobilized ligands. J. Biol. Chem., 268: 15868-15877, 1993.
46. Laventhal, P. S., Shelden, E. A., Kim, B., and Feldman, E. L. Tyrosine phosphorylation of paxillin and focal adhesion kinase during insulin-like growth factor-1-stimulated lamellipodia advance. J. Biol. Chem., 272: 5214-5218, 1997.
47. Marushige, Y., and Marushige, K. Alterations in focal adhesion and cytoskeletal proteins during apoptosis. Anticancer Res., 18: 301-308, 1998.
48. Yang, C., Chang, J., Gorospe, M., and Passaniti, A. Protein tyrosine phosphatase regulation of endothelial cell apoptosis and differentiation. Cell Growth Differ., 7: 161-171, 1996.
49. FAK in cultured fibroblasts results in apoptosis. J. Cell Biol., 135: 1383-1390, 1996.
50. Xu, L., Owens, L. V., Sturge, G. C., Yang, X., Liu, E. T., Craven, R. J., and Cance, W. G. Attenuation of the expression of focal adhesion kinase induces apoptosis in tumor cells. Cell Growth Differ., 7: 413-413, 1996.
51. Fukai, F., Mashimo, M., Akiyama, K., Goto, T., Tanuma, S., and Katayama, T. Modulation of apoptotic cell death by extracellular matrix proteins and a fibronectin-derived antiadhesive peptide. Exp. Cell Res., 242: 92-99, 1998.
52. Frisch, S. M., and Francis, H. Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol., 124: 619-626, 1994.
53. Meredith, J. E., Jr., Fazeli, B., and Schwartz, M. A. The extracellular matrix as a cell survival factor. Mol. Biol. Cell., 4: 953-961, 1993.
54. v Integrins mediate adhesion and migration of breast carcinoma cell lines. Clin. Exp. Metastasis, 16: 50-61, 1998.